Cargando…
Healthcare Professional Preferences for Prescribing Artemisinins and Quinine for Malaria in Burundi
BACKGROUND: Malaria is a significant cause of morbidity and mortality throughout the world and particularly sub-Saharan Africa. The World Health Organization and many national bodies, including Burundi, recommend artemisinin-based therapy as first-line treatment for uncomplicated and severe malaria....
Autores principales: | Niyonkuru, Aîné-Ernest, McLaughlin, Eric, Heath, Gregory, Inamuco, Sonia, Topazian, Hillary, Davis, Mike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The East African Health Research Commission
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751477/ https://www.ncbi.nlm.nih.gov/pubmed/35036845 http://dx.doi.org/10.24248/eahrj.v5i2.670 |
Ejemplares similares
-
Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi
por: Amuasi, John H, et al.
Publicado: (2011) -
Artemisinin derivatives versus quinine in treating severe malaria in children: a systematic review
por: PrayGod, George, et al.
Publicado: (2008) -
Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya
por: Watsierah, Carren A, et al.
Publicado: (2014) -
Geo-additive modelling of malaria in Burundi
por: Nkurunziza, Hermenegilde, et al.
Publicado: (2011) -
Exploring predictive frameworks for malaria in Burundi
por: Mfisimana, Lionel Divin, et al.
Publicado: (2022)